- Home
- NRSN vs RVP Comparison
NRSN vs RVP Comparison
Compare NRSN & RVP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NRSN
- RVP
- Stock Information
- Founded
- NRSN 2017
- RVP 1994
- Country
- NRSN Israel
- RVP United States
- Employees
- NRSN N/A
- RVP N/A
- Industry
- NRSN Biotechnology: Pharmaceutical Preparations
- RVP Medical/Dental Instruments
- Sector
- NRSN Health Care
- RVP Health Care
- Exchange
- NRSN Nasdaq
- RVP Nasdaq
- Market Cap
- NRSN 26.3M
- RVP 21.7M
- IPO Year
- NRSN 2021
- RVP 2001
- Fundamental
- Price
- NRSN $1.31
- RVP $0.68
- Analyst Decision
- NRSN
- RVP
- Analyst Count
- NRSN 0
- RVP 0
- Target Price
- NRSN N/A
- RVP N/A
- AVG Volume (30 Days)
- NRSN 181.1K
- RVP 62.5K
- Earning Date
- NRSN 11-26-2024
- RVP 11-19-2024
- Dividend Yield
- NRSN N/A
- RVP N/A
- EPS Growth
- NRSN N/A
- RVP N/A
- EPS
- NRSN N/A
- RVP N/A
- Revenue
- NRSN N/A
- RVP $38,253,271.00
- Revenue This Year
- NRSN N/A
- RVP N/A
- Revenue Next Year
- NRSN N/A
- RVP N/A
- P/E Ratio
- NRSN N/A
- RVP N/A
- Revenue Growth
- NRSN N/A
- RVP N/A
- 52 Week Low
- NRSN $0.47
- RVP $0.62
- 52 Week High
- NRSN $2.33
- RVP $1.34
- Technical
- Relative Strength Index (RSI)
- NRSN 61.44
- RVP 31.82
- Support Level
- NRSN $1.23
- RVP $0.71
- Resistance Level
- NRSN $1.34
- RVP $0.75
- Average True Range (ATR)
- NRSN 0.10
- RVP 0.02
- MACD
- NRSN 0.01
- RVP 0.00
- Stochastic Oscillator
- NRSN 75.00
- RVP 0.00
About NRSN NeuroSense Therapeutics Ltd.
NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases, these diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease and Parkinson's disease, among others. Its product candidate, PrimeC, is a novel extended-release, or ER, oral formulation of a fixed dose combination of two generic FDA-approved drugs, ciprofloxacin and celecoxib, combined in a specific ratio.
About RVP Retractable Technologies Inc.
Retractable Technologies Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession. The company's products are the VanishPoint 0.5mL insulin syringe; 1mL tuberculin, insulin, and allergy antigen syringes; 0.5mL, 1mL, 2mL, 3mL, 5mL, and 10mL syringes; the small diameter tube adapter; the blood collection tube holder; the allergy tray; the IV safety catheter; the Patient Safe syringes; the Patient Safe Luer Cap; the VanishPoint Blood Collection Set; and the EasyPoint needle, as well as a standard 3mL syringe packaged with an EasyPoint needle. The company also sells VanishPoint autodisable syringes in the international market in addition to the Company's other products.